Institute of Molecular Physiology and Genetics
International grants: |
|
 |
Project CELGENE (2009-2014) Principal Investigator: Albert Breier (Contract with the Celgene company). |
|
NATO Grant PDD(CP)-(CBP.NUKR.CLG 982646) P-glycoprotein Mediated Multidrug Resistance in Radiation-Associated Hematological Malignancies Following the Chernobil Accident (2007-2008) Principal Investigator: Albert Breier |
Slovak Research and Development Agency (APVV): |
|
| APVV-0282-11 Preparation of nanostructured interfaces, their integration with bioelements and subsequent use (2012-2015) Principal Investigator (Institute of Chemistry, SAS): Ján Tkáč Principal Investigator at IMPG SAS: Zdena Sulová |
|
| APVV-0160-11 Antitumour effect of biologically active ligands of nuclear retinoid X receptor heterodimers in tissue carcinoma cell lines (2012-2015) Principal Investigator (Institute of experimental Endocrinology, SAS): Július Brtko Principal Investigator at IMPG SAS: Zdena Sulová |
|
|
APVV-0290-10 Alteration in cell metabolism asocciated with drug transporter P-glycoprotein overexpression in leukemia cells (2011-2014) Principal Investigator: Zdena Sulová |
| APVV-0084-07 Overexpression of P-glycoprotein and associated changes in spectrum and levels oligo- and polysaccharides (2008-2010) Principal Investigator: Zdena Sulová |
|
Grant Agency for Science (VEGA): |
|
|
VEGA 2/0182/13 Multidrug resistance of leukemia cells on different drugs (2013-2016) Principal investigator: Zdena Sulová |
|
VEGA 2/0100/12 Overexpression of P-glycoprotein-induced cell changes in leukemia cells (2012-2014) Principal Investigator: Albert Breier |
|
VEGA 2/0123/10 The effect of P-glycoprotein and development of multidrug resistance on some aspects of metabolism (2010-2012) Principal Investigator: Zdena Sulová |
|
VEGA 2/0155/09 Changes of leukemia cells associated with P-glycoprotein mediated multidrug resistance development (2009-2011) Principal Investigator: Albert Breier |